Search clinical trials for: Gefitinib group

Total 10562 results

AstraZeneca

Completed

Combination Casodex® and Iressa™ in Locally Advanced Prostate Cancer

Locally Advanced Prostate Cancer

Norway
AstraZeneca

Completed

Open Label Trial to Assess Iressa in Prostate Cancer Patients

Prostate Cancer
Aqua Medical Services (Pvt) Ltd

Completed

Decompression With ELDOA on Lumbar Disc Protrusion Patient

Lumbar Disc Herniation | Spinal Disk Injury | Protrusion

Pakistan
Foundation University Islamabad

Completed

Effects of Structured Exercise Regime in Gestational Diabetes Mellitus

Gestational Diabetes Mellitus

Pakistan
University of Florida

Completed

The Effect of AGE on the Immune System (EAGESIS II)

Healthy

United States
Cairo University

Completed

Timing of Umbilical Cord Clamping in Preterm Neonates

Cord Clamping

Egypt
Al-Azhar University

Completed

the Condylar Response of Mini-plate Anchored Rigid Fixed Functional Appliance Versus Dentally Anchored Semi-rigid One

Class II Malocclusion

Egypt
Zagazig University

Completed

Different Maneuvers for Reducing Post-laparoscopic Pain

Gynecologic Disease

Egypt
Riphah International University

Completed

Whole-body Vibration in Spastic Hemiplegic Cerebral Palsy

Cerebral Palsy, Spastic

Pakistan
Riphah International University

Completed

Exergame Balance Training for Patients With Mild Cognitive Impairment

Mild Cognitive Impairment

Pakistan
ThinkWell
University of Oxford; Queen's University, Belfast; The BMJ

Completed

How Frequently and in What Format Are Research Trial Results Disseminated to Participants (ResponseQT) (ResponseQT)

Motivation

United Kingdom
Fundacio d'Investigacio en Atencio Primaria Jordi...
Hospital Universitari Vall d'Hebron Research Institute; Centre d'Higiene Mental...

Unknown

Evaluation of a Psychoeducation Group Program for Mild/Moderate Depression

Depressive Disorders

Spain
University of Chicago

Completed

A Phase II Study of 250-mg ZD1839 Monotherapy in Recurrent or Metastatic or Both Recurrent and Metastatic Squamous Cell Carcinoma

Head and Neck Cancer

United States
University of Chicago
AstraZeneca

Completed

Phase II Study of Skin Toxicity Dosing of IRESSA (Gefitinib) in Squamous Cell Carcinoma of the Head and Neck

Head and Neck Neoplasms

United States
University of Pittsburgh
AstraZeneca

Completed

Study of Gefitinib and Docetaxel as Salvage Therapy in Advanced Pancreatic Carcinoma

Cancer

United States
Asan Medical Center
AstraZeneca

Unknown

First Line Gefitinib by FDG-PET Metabolic Response

Non-small Cell Lung Cancer

Korea, Republic of
AstraZeneca

Withdrawn

Maintenance ZD1839 (IRESSA®) Following Completion of Front Line, Platinum-Based, Double Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (IMAC/Herbst)

Non-Small-Cell Lung Carcinoma
AstraZeneca

Completed

Study Evaluating Gefitinib (IRESSA®) in Subjects With Solid Malignancies That Are Locally Advanced, Recurrent or Metastatic (AGUS)

Tumors

United States
Nantes University Hospital
Fondation Apicil

Terminated

Attentional Re-training for Chronic Pain Patients (ABCD)

Chronic Pelvic Perinal Pain

France
The Hong Kong Polytechnic University
The University of Hong Kong

Completed

Effectiveness of Training in Reading Rehabilitation for Patients With Diabetic Macular Oedema

Diabetic Macular Oedema | Parafoveal Scotoma

China
Hepatopancreatobiliary Surgery Institute of Gansu...

Completed

Effect of Endoscopic Papillary Balloon Dilation on ERCP Complications

Complications

China
University of British Columbia
Canadian Institutes of Health Research (CIHR); Provincial Health Services Authority and other collaborators

Completed

Educational Interventions for Chronic Obstructive Pulmonary Disease (COPD) Self-management in Ethno-cultural Communities (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

Canada
University of California, San Francisco
National Institute on Aging (NIA); Alzheimer's Association; Posit Science Corporation and other collaborators

Completed

The Mental Activity and eXercise Trial for Seniors (MAX)

Cognitive Impairment

United States
Hunan Province Tumor Hospital

Recruiting

Real World Study on Erlotinib/Gefitinib Combined With Bevacizumab in Advanced Non-aquamous Non-small Cell Lung Cancer

Non Small Cell Lung Cancer

China
National Cancer Institute (NCI)

Completed

Gefitinib and Capecitabine in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
AstraZeneca

Terminated

Gefitinib in Combination With Chemoradiation in Resectable Gastric Cancer

Subjects With Resectable Local or Locally Advanced, Non-Metastatic (T2-T4, N0-N3, M0; Stages II and III) and Histologically-Confirmed Intestinal GC

Finland
Lady Davis Institute
Jewish General Hospital

Unknown

A Open-label Prospective Cohort Trial of Curcumin Plus Tyrosine Kinase Inhibitors (TKI) for EGFR -Mutant Advanced NSCLC (CURCUMIN)

Lung Cancer

Canada
Chang Gung University

Recruiting

Effects of Combined Cognitive Training and Rhythmic Auditory Stimulation in Treadmill Training After Stroke

Stroke

Taiwan
Karaman Training and Research Hospital

Recruiting

Effect of Preoperative Oral Carbohydrate Loading on Elderly Patient Quality of Recovery in Total Knee Arthroplasty

Quality Of Recovery

Turkey
Universidad Politecnica de Madrid
Universidad Politécnica de Madrid.

Completed

Effects of a Mindfulness Programme on Competitive Athletes With Physical Disabilities

Chronic Pain | Athletic Injuries | Physical Disability

Spain
California Cancer Consortium
National Cancer Institute (NCI)

Terminated

Gefitinib and PEG-Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer

Kidney Cancer

United States
Shanghai Chest Hospital
Changhai Hospital; Ruijin Hospital

Unknown

Chemotherapy Plus Gefitinib for Advanced Lung Adenocarcinoma and Sensitive EGFR Mutations: a Randomized Controlled Trial

Lung Adenocarcinoma
Mansoura University

Completed

Comparative Study of the House Advancement Flap, Rhomboid Flap, and Y-V Anoplasty

Anal Stenosis

Egypt
Somogy Megyei Kaposi Mór Teaching Hospital

Completed

Neuro-rehabilitation Training Effects on Motion and Quality of Life After Acute Stroke and Post Stroke

Stroke

Hungary
Sunshine Lake Pharma Co., Ltd.

Active, not recruiting

Ningetinib (CT053PTSA) Plus Gefitinib in Stage IIIB or IV NSCLC Patients With EGFR Mutation and T790M Negative

Non-small Cell Lung Cancer

China
AstraZeneca

Approved for marketing

Open Label Extension Study With Gefitinib (IRESSA™) for Completing Trial Patients Who May Benefit From Further Treatment

Non Small Cell Lung Cancer (NSCLC)

Taiwan, Thailand, Turkey, Brazil, Philippines, Russian Federation, Romania, Austria, Hungary, Bulgaria, Latvia, India, Argentina, Australia, Estonia, Malaysia, Mexico, Singapore, South Africa
Papworth Hospital NHS Foundation Trust
AstraZeneca; Noble Organisation

Terminated

Feasibility Study to Estimate Number of Patients With Precancerous Areas in Their Airways and the Response to Gefitinib (TIDAL1)

Head and Neck Cancer | Lung Cancer

United Kingdom
Stanford University
AstraZeneca; American Society of Clinical Oncology

Completed

Cisplatin and ZD1839 + Re-Irradiation in Recurrent Squamous Cell Cancer of the Head and Neck

Head and Neck Cancer | Carcinoma, Squamous Cell

United States
Juan F. Masa
Rush University Medical Center

Withdrawn

"Post-acute Pickwick Study" (Postacute-Pick-2020)

Acute on Chronic Hypercapnic Respiratory Failure | Obesity Hypoventilation Syndrome (OHS)
Tasly Pharmaceutical Group Co., Ltd

Completed

A Study to Evaluate the Tolerability and Pharmacokinetics of Jiashen Tablets in Healthy Subjects

Healthy

China
Novartis Pharmaceuticals

Completed

A Safety and Efficacy Study of INC280 and Gefitinib in Patients With EGFR Mutated, c-MET-amplified NSCLC Who Have Progressed After EGFRi Treatment

Non-small Cell Lung Cancer

China, Taiwan, Belgium, Netherlands, Spain, Germany, Singapore, Italy, Japan, Australia, Israel, Korea, Republic of, Thailand, France
AstraZeneca

Completed

Efficacy, Safety, Tolerability of Gefitinib as 1st Line in Caucasian Patients With EGFR Mutation Positive Advanced NSCLC (IFUM)

Caucasian Patients With EGFR Mutation Positive Advanced NSCLC

Bulgaria, Italy, Poland, Spain, Turkey, United Kingdom, Romania, Norway, Hungary, Portugal, Greece, Switzerland, France
Shanghai Chest Hospital

Unknown

Comparator-Controlled Study for EGFR(+) Patients With Multiple BMs From NSCLC (BROKE) (EGFR-epidermal Growth Factor Receptor;BM-brain Metastases) (EGFR)

Non-Small Cell Lung Cancer | Brain Metastases | EGFR Gene Mutation

China
Indiana University School of Medicine
AstraZeneca

Terminated

A Phase II Study of Iressa in Patients With Chemo Refractory Germ Cell Tumors Expressing EGFR (IUCRO-0021)

Refractory Germ Cell Tumors Expressing EGRF

United States
AstraZeneca

Completed

An Open-label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant Mesothelioma

Mesothelioma
AstraZeneca

Completed

Gefitinib (Iressa) in Combo With Chemoradiation in Patients With Locally Advanced Head & Neck Cancer

Head and Neck Neoplasms

Finland
Mersin University

Completed

The Effect of Acupressure on Fatigue

Interventional

Turkey
Mansoura University

Completed

Isolated Roux Loop Pancreaticojejunostomy Versus Pancreaticogastrostomy After Pancreaticoduodenectomy (PD)

Pancreatic Fistula After Pancreaticoduodenectomy

Egypt
University of California, San Francisco
Mount Zion Health Fund; Pritzker Family Foundation; Mental Insight Foundation

Completed

Treating Major Depression With Yoga: A Prospective, Randomized Controlled Pilot Trial

Depression, Unipolar

United States
ThinkWell
University of Oxford; Queen's University, Belfast; The BMJ

Completed

The Role of Supplementary Material in Journal Articles QT (SupMatQT)

Incentive

United Kingdom

Search clinical trials for: Gefitinib group

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations